Medvarsity Logo
Guidelines for Management- Dialysis Safety

CASE DISCUSSION

Guidelines for Management- Dialysis Safety

India flagPresented India by Dr. Satyanarayana Garre

Views

5,195

Case Description

Usually, additional medications to imitate kidney functions are needed for dialysis patients. Phosphate binders and erythropoiesis-stimulating substances fall under this category. Any medications a patient is taking should be evaluated because many medications rely on the kidneys for clearance and...

Case Summary

  • Dialysis, derived from the Greek word meaning "dissolution," involves the movement of molecules across a semi-permeable membrane. Hemodialysis specifically refers to this process when it occurs in contact with blood using an artificial membrane. Thomas Graham first demonstrated solute movement across a semi-permeable membrane, while Avil and Rontri performed the first dialysis on dogs. The first human hemodialysis was performed by Dr. Haas, though it faced complications. Dr. John Paul created the first working dialysis machine, and Albert Kittley developed an improved model.

Speaker Profile

Dr. Satyanarayana Garre

Dr. Satyanarayana Garre

MBBS, MD, DNB( Nephrology) Apollo hospitals Hyderabad
Dr. Satyanarayana Garre is a Nephrologist associated with Apollo Hospitals with expertise in kidney diseases and renal care. He holds MBBS, MD, and DNB in Nephrology, reflecting advanced training in internal medicine and nephrology. His clinical interests include chronic kidney disease, dialysis management, hypertension, electrolyte disorders, and preventive renal healthcare. He is committed to providing evidence-based and patient-centered nephrology care using advanced diagnostic and treatment approaches. Through his clinical practice, he contributes to improving kidney health outcomes and comprehensive renal care services.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.